Integra Connect Commends its Network for Improving Patient Outcomes, While Generating Revenue for Practices and Cost Savings for CMS
WEST PALM BEACH, Florida., October 20, 2022 /PRNewswire/ — Integra Connect, LLC., a leader in value-based precision medicine solutions for specialty care, today announced that its community oncology practice network has resulted in measurable improvements in cancer care during the most recent performance period of the Center for Oncology Model of Care (OCM) of Medicare & Medicaid Innovation (CMMI). Across the network, participating practices scored high on key quality measures, some with perfect scores, and resulted in a 28% reduction in inpatient care services. Since OCM’s inception, Integra Connect’s network of practices has generated over $250 million value-based care income, of which nearly $100 million in performance-based payments for practices, helping to prepare organizations for success with the next iteration of CMS’s value-based cancer care model – the Oncology Improvement Model (EOM).
“Cancer care has always been complicated, but value-based care and clinical advancements have added another level of complexity. We succeed with value-based care because our providers are committed to improving cancer outcomes for their patients and consistently leverage technology through the entire process. practice,” said Dr. Sibel Blaumedical director at Northwest Medical Specialties (Tacoma, WA). “That’s why we chose to engage with Integra Connect, which provides our practice with insights related to clinical considerations, cost drivers, opportunities for improvement and works with us side-by-side to ensure our organization responds. to our value-based care business, operational and clinical objectives.”
Armed with clinical and claims data and sophisticated near real-time analytics from Integra Connect, practices were able to:
- Identify at-risk patients, predict potential outcomes, and take action, which has helped providers achieve high quality scores.
- Navigate through forms and select potentially appropriate treatments for each patient based on cancer type, drug efficacy, cost, and OCM participation. This resulted in drug spending control, practice-wide, which had a huge impact on their total CMO spend.
- Recognizing opportunities for improved care and finances and taking action, resulting in a 38% reduction in end-of-life costs.
As a result, over OCM’s 10 performance period, Integra Connect’s practice network generated savings from target price of nearly $2,000 per episode – marking the highest savings rate per episode achieved by Integra Connect practices since OCM’s inception in 2016.
“We are proud of our continued success with OCM and the abilities of our oncology providers to deliver high-quality cancer care, enabled by Integra Connect’s patient, practice, and population-level analytics,” said Ruth Dunexecutive director of the Oklahoma Cancer Specialists & Research Institute at Tulsa, Oklahoma. “Our patient outcomes and financial performance demonstrate that using technology powered by clinical and claims data is imperative for those seeking to succeed with value-based care.”
“Integra Connect is proud to work with leading community oncology practices to propel value-based care and enable providers to deliver high-quality care to those battling cancer,” said Dr. Jeffrey Scott, Chief Medical Officer and President of Population Health Solutions, Integra Connect. “It has been incredibly rewarding to see how our practices’ clinical and financial performance has improved since OCM’s inception, and we welcome the opportunity to further help them succeed with value-based care through programs such as EOM and alternative payment models from commercial payers.
About Integra Connect, LLC.
Integra Connect is a value-driven precision medicine company that leads the industry in real-world data and analytics capabilities for oncology. With data from more than 11 million unique patient lives, decades of expertise in value-based care, and sophisticated technologies, it enables specialty care providers, health systems, payers, and businesses to life sciences to improve patient outcomes, provider decision-making, business operations and performance and clinical research to succeed within value-based models of care.
Since its inception, Integra Connect has supported more than 5,000 providers, six payers and a host of life science companies in their efforts to advance value-based precision medicine. Notably, Integra Connect has enabled more than 1,500 oncology providers and payers to succeed within the oncology model of care, generating more than $250 million in value-based care income and nearly $100 million in shared economies, supported the creation and launch of alternative payment models for oncology, and leveraged our real-world clinical and claims data set to enable life science research on medical advances from precision.
For more information, please visit www.integraconnect.com or follow Integra Connect on LinkedIn
240 816 1645
SOURCE Integra Connect